BCL2 and diffuse large B-cell lymphoma: In addition to mutational status and involvement of BCL-2 family members, regulators of energy metabolism have been identified as drivers of venetoclax resistance in CLL and diffuse large B-cell lymphoma (DLBCL) [11].